(Q38971615)

8 September 2017

title

ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy (English)

1 reference

8 September 2017

1 reference

ovarian serous carcinoma

1 reference

Ozlen Saglam

1

1 reference

8 September 2017

Yin Xiong

2

1 reference

8 September 2017

Douglas C Marchion

3

1 reference

8 September 2017

Carolina Strosberg

4

1 reference

8 September 2017

Robert M Wenham

5

1 reference

8 September 2017

Joseph J Johnson

6

1 reference

8 September 2017

Daryoush Saeed-Vafa

7

1 reference

8 September 2017

Christopher Cubitt

8

1 reference

8 September 2017

Ardeshir Hakam

9

1 reference

8 September 2017

Anthony M Magliocco

10

1 reference

8 September 2017

publication date

1 January 2017

1 reference

8 September 2017

1 reference

8 September 2017

volume

24

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

89-95

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

8 September 2017

1 reference

The biology of ovarian cancer: new opportunities for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Rethinking ovarian cancer: recommendations for improving outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

The ERBB network: at last, cancer therapy meets systems biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Function of ERBB4 is determined by alternative splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

The ERalpha coactivator, HER4/4ICD, regulates progesterone receptor expression in normal and malignant breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Cell death or survival promoted by alternative isoforms of ErbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Characterization of EGFR family gene aberrations in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Role of ErbB4 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

The ERBB4/HER4 intracellular domain 4ICD is a BH3-only protein promoting apoptosis of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Expression profiling of the ovarian surface kinome reveals candidate genes for early neoplastic changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Expression and significance of HER family receptors in neuroblastic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Low-grade serous carcinoma of the ovary or peritoneum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Co-treatment of wild-type EGFR head and neck cancer cell lines with afatinib and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481702400115

Characteristics of EGFR family-mediated HRG signals in human ovarian cancer

21 January 2018

1 reference

12 December 2020

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer.

1 reference

12 December 2020

Neuregulin expression, function, and signaling in human ovarian cancer cells.

1 reference

12 December 2020

Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms

1 reference

12 December 2020

HER4 is a novel prognostic biomarker in gastrointestinal stromal tumor specifically originated from stomach.

1 reference

12 December 2020

Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigation

1 reference

12 December 2020

10.1177/107327481702400115

Identifiers

DOI

0 references

PMC publication ID

7771303

0 references

1 reference